Daniel S. Costandy
Associate
Danny Costandy specializes in his practice at the intersection of our Business Law Department and our Healthcare Practice Group. With a deep understanding of the complexities of healthcare regulation and a strong foundation in business law, he brings a unique perspective to our legal team. Danny is committed to providing strategic legal solutions to clients in the healthcare industry, helping them navigate the ever-changing landscape of healthcare regulations and business transactions. Danny began at Foley as a summer associate and also worked for the US Navy JAG Corp in San Diego as a summer intern.
Presentations and Publications
- Co-author, “Health Care Enforcement: ‘Tea Leaves’ in the 2024 National Health Care Fraud Summer Takedown,” Health Care Law Today (August 28, 2024)
- Co-author, “Artificial Intelligence: Is the Health Care Sector Ready for the Rollout?,” Health Care Law Today (August 19, 2024)
Health Care Enforcement: “Tea Leaves” in the 2024 National Health Care Fraud Summer Takedown
Each summer in recent years, the U.S. Department of Justice and associated fraud enforcement partners have indicted many health care defendants, in multiple cases across the country. This summer continued the tradition.
Artificial Intelligence: Is the Health Care Sector Ready for the Rollout?
On July 17, 2024, Foley & Lardner LLP hosted the Boston Health Care AI & Technology Investor Summit with Endeavor Venture Funds, bringing together hundreds of attendees in person and virtually to discuss issues surrounding the rollout of artificial intelligence (AI) solutions for the health care sector.
Medicare Overpayments: CMS Proposes Regulation Establishing Six Month Suspended Deadline for 60-Day Refund Rule
The 60-day Refund Rule, created by the 2010 Affordable Care Act, requires providers to report and return Medicare and Medicaid overpayments within 60 days of identifying them.
Colorado Passes New AI Law to Protect Consumer Interactions
With the passage of SB205, Colorado has enacted the first comprehensive legislation covering both developers and users of “high-risk artificial intelligence systems.”
Health Care Private Equity: Senate Budget Committee Investigates Hospital Ownership
On December 7, 2023, the Senate Budget Committee launched a bipartisan investigation into the reality of private equity ownership of hospitals in the United States.
Decentralized Clinical Trials: Diversity in Clinical Trials
The U.S. Food and Drug Administration (FDA) has demonstrated a commitment to expanding diversity in clinical trials.